On September 21st, Sirio, one of the leading global contract developers and manufacturers of nutritional supplements, announced its plan to repurchase company shares using its own funds of RMB 40 million yuan (USD $5.48 million), which would represent 0.55% of the total company shares. Similarly, on September 21st, CSPS Innovation, one of China’s leading companies in the functional food industry, disclosed its plan to repurchase 20 million shares using its own funds of RMB 422 million yuan (USD $57.8 million), accounting for 1.71% of the total company shares. Typically, when publicly listed companies buy back their own shares, it sends a positive signal to the market, helping to boost investor confidence. It is reported that both Sirio Pharma and CSPS Innovation plan to use the repurchased shares for employee stock ownership or equity incentives, indicating their optimistic outlook for the future development of the companies and the health food industry. (Source: shuzhengkangxun)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE